Mono-POC Ethyl Tenofovir
| Product Name | Mono-POC Ethyl Tenofovir |
|---|---|
| Alternate Names | Tenofovir Impurities, Impurities of Tenofovir |
| CAT No. | CS-O-11174 |
| CAS No. | 1796539-92-8 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 431.38 g/mol |
| Mol. For. | C16H26N5O7P |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Tenofovir |
| Purity | Not less than 90 % |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | C[C@@H](OC[P](OCOC(OC(C)C)=O)(OCC)=O)CN1C2=NC=NC(N)=C2N=C1 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Mono-POC Ethyl Tenofovir is a novel prodrug of Tenofovir, which is used in the treatment of HIV and Hepatitis B virus infections. It is a nucleotide analog reverse transcriptase inhibitor that works by blocking the replication of the virus. Mono-POC Ethyl Tenofovir is designed to improve the bioavailability and pharmacokinetics of Tenofovir, thereby reducing the frequency of dosing and minimizing adverse effects.
The chemical structure of Mono-POC Ethyl Tenofovir consists of a phosphonamidate prodrug linked to a lipophilic ethyl group. The lipophilic nature of this compound allows for increased cellular uptake and better distribution into the target cells. The prodrug is selectively activated by esterases in the plasma and liver, releasing the active form of Tenofovir.
Mono-POC Ethyl Tenofovir is administered orally and has been studied in clinical trials for its safety and efficacy. It has shown promising results in reducing viral load and improving immune function in HIV-infected patients. Additionally, it has been found to be effective in the treatment of chronic Hepatitis B infections.
In conclusion, Mono-POC Ethyl Tenofovir is a prodrug of Tenofovir that has been designed to improve its bioavailability and pharmacokinetics. It has shown promising results in the treatment of HIV and Hepatitis B virus infections and may offer a safer and more effective alternative to current therapies.
Get an Instant Quote
Related Compounds
Tenofovir Impurity 89 | Tenofovir Disoproxil Fumarate Impurity | Tenofovir isomer 6&1 | Tenofovir Alafenamide fumarate | Tenofovir alafenamide Impurity 5 | MOC-POC Tenofovir Fumarate | Tenofovir Disoproxil T5 Impurity | Tenofovir Mono-POC methyl ester | Tenofovir Related Compound 5 | Tenofovir Impurity 65 | Tenofovir Mixed dimer | Tenofovir impurity C fumarate salt | TAF Propyl ester Impurity | Tenofovir Alafenamide (RSR) Diasteroisomer | MOC-POC Tenofovir | Tenofovir alafenamide Impurity 1 | Tenofovir alafenamide lactose Millard Reaction product-3 | Tenofovir Alafenamide Racemic D Isomer | Tenofovir Disoproxil Fumarate USP RC J | nPOC-POC Tenofovir Fumarate | tenofovir related impurity | Tenofovir Disoproxil T8 Impurity | Tri-POC Tenofovir Dimer | Mono ester impurity (Tenofovir) | Tenofovir Impurity 59 | Tenofovir Disoproxil Dimer | Mono-POC Methyl Tenofovir Fumarate (Mixture of Diastereomers) | Mono poc-isopropyl-Tenofovir fumarate salt | Tenofovir Disoproxil Isopropoxycarbonyl | Tenofovir DP-V | Tenofovir Disoproxil (S)-Isomer fumarate salt | Tenofovir Alfenamide Amadori Rearrangement product | Tenofovir Alafenamide Glycosamine product | Tenofovir alafenamide Impurity 3 | Tenofovir diphosphate | Tenofovir Bis ((R)-9-(2-Hydroxypropyl)adenine) dimer Acetate salt | Tenofovir alafenamide lactose Millard Reaction product-2 | TAF SRS diastereomer | Tenofovir Isopropyl Carbamate | Tenofovir DP-IV | Tenofovir EP Impurity C Succinate | Tenofovir disoproxil phosphate | Tenofovir Impurity 36 (RSR) 2,3-dihydroxysuccinate salt | Tenofovir Mono POC Dimer Diethyl amine salt | TenofovirDisoproxil Ethyl fumarate Impurity | Mono-POC Tenofovir 6-Isopropyl Carbamate | Tenofovir alafenamide monofumarate | Tenofovir Diphenyl HemiFumarate salt | Diethylaminocarboxymethyl POC Tenofovir (Mixture of Diastereomers) | Desmethyl Tenofovir Disoproxil Fumarate | Diisopropyl Tenofovir Fumarate | Tenofovir Alafenamide Dimer impurity | Diethylaminocarboxymethyl POC Tenofovir Fumarate | Tenofovir alafenamide impurity | Tenofovir Impurity 98 | Tenofovir alafenamide Impurity 2 | Ethyl Tenofovir Impurity | Tenofovir Disoproxil T12 Impurity | Tenofovir Impurity 59-D6 | Tenofovir Alanine ester impurity | Tenofovir Impurity 39 (RRR) 2,3-dihydroxysuccinate salt | Tenofovir Disoproxil T7 Impurity | nPOC-POC Tenofovir | Desmethyl Tenofovir disoproxil | Isopropyl Tenofovir | Tenofovir Alafenamide Dimer Impurity II | Tenofovir Impurity 62 | Tenofovir disoproxil impurity L | Tenofovir Alafenamide N-hydroxy methyl impurity | Tenofovir alafenamide (RRS) diasteroisomer |